An updated report from the AARP Public Policy Institute shows the growth in retail prices for many brand name prescription
The Centers for Medicare & Medicaid Services (CMS) took additional steps this week to make COVID-19 vaccines available to Medicare
Last week, President Biden submitted his first budget request to Congress. The White House plan includes legislative proposals and detailed funding
In early 2020, Congress and the Centers for Medicare & Medicaid Services (CMS) added temporary telehealth flexibilities to Medicare to
On Tuesday, the Centers for Medicare & Medicaid Services (CMS) updated COVID-19 vaccination education, uptake, and reporting policies for Medicaid
On May 4, the U.S. House Committee on Energy and Commerce, Subcommittee on Health held a hearing on drug pricing legislation, including
A new research article published in Health Affairs examines the supplemental coverage “cliff” that some people with Medicare may experience. These beneficiaries
Though major legislative and regulatory solutions have stalled in recent years, policymakers are once again turning their attention to the
Several departments within the U.S. Department of Health and Human Services (HHS)— the Office for Civil Rights (OCR), the Administration
The Centers for Medicare & Medicaid (CMS) recently released new data on the impact of COVID-19 on people with Medicare,
An updated report from the AARP Public Policy Institute shows the growth in retail prices for many brand name prescription
The Centers for Medicare & Medicaid Services (CMS) took additional steps this week to make COVID-19 vaccines available to Medicare
Last week, President Biden submitted his first budget request to Congress. The White House plan includes legislative proposals and detailed funding
In early 2020, Congress and the Centers for Medicare & Medicaid Services (CMS) added temporary telehealth flexibilities to Medicare to
On Tuesday, the Centers for Medicare & Medicaid Services (CMS) updated COVID-19 vaccination education, uptake, and reporting policies for Medicaid
On May 4, the U.S. House Committee on Energy and Commerce, Subcommittee on Health held a hearing on drug pricing legislation, including
A new research article published in Health Affairs examines the supplemental coverage “cliff” that some people with Medicare may experience. These beneficiaries
Though major legislative and regulatory solutions have stalled in recent years, policymakers are once again turning their attention to the
Several departments within the U.S. Department of Health and Human Services (HHS)— the Office for Civil Rights (OCR), the Administration
The Centers for Medicare & Medicaid (CMS) recently released new data on the impact of COVID-19 on people with Medicare,
